ArticleFrontiers in pharmacology2022

A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs.

Yang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.